Vivos Therapeutics(VVOS.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Vivos Therapeutics
VVOS.US
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.
416.95 B
VVOS.USMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
Health Care ServicesIndustry
Industry Ranking60/87
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-655.01%E
    • Profit Margin-121.37%E
    • Gross Margin60.44%A
  • Growth ScoreC
    • Revenue YoY16.05%B
    • Net Profit YoY-90.10%E
    • Total Assets YoY64.56%A
    • Net Assets YoY-119.49%E
  • Cash ScoreB
    • Cash Flow Margin72.10%C
    • OCF YoY16.05%B
  • Operating ScoreB
    • Turnover0.86B
  • Debt ScoreE
    • Gearing Ratio106.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    TRAW Q1'26 Earnings: EPS estimate is (0.56) USD

    TradingView·
    US
    TRAW
    -9.66%
    US
    VHT
    +0.97%
    US
    PBE
    +0.11%
    TradingView·
    US
    TRAW
    -9.66%
    US
    VHT
    +0.97%
    US
    PBE
    +0.11%

    12 Health Care Stocks Moving In Thursday's Intraday Session

    benzinga_article·
    US
    LIMN
    +1.55%
    US
    CDNA
    -0.29%
    US
    QDEL
    +4.98%
    benzinga_article·
    US
    LIMN
    +1.55%
    US
    CDNA
    -0.29%
    US
    QDEL
    +4.98%

    Vivos Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.

    benzinga_article·
    US
    VVOS
    -2.32%
    US
    XHE
    +0.66%
    US
    XLV
    +1.10%
    benzinga_article·
    US
    VVOS
    -2.32%
    US
    XHE
    +0.66%
    US
    XLV
    +1.10%

    Vivos Therapeutics Inc Full Year Sales Increase

    nasdaq·
    US
    VVOS
    -2.32%
    US
    IHI
    +1.00%
    US
    XLV
    +1.10%
    nasdaq·
    US
    VVOS
    -2.32%
    US
    IHI
    +1.00%
    US
    XLV
    +1.10%

    Vivos Therapeutics | 8-K: FY2025 Revenue: USD 17.44 M

    Earnings Watch·
    US
    VVOS
    -2.32%
    Earnings Watch·
    US
    VVOS
    -2.32%
    © 2026 Longbridge｜Disclaimer